Breaking News Headlines Today | Ground News

See every side of every news story

Eyewire+ image

News from Eyewire+

Stay current with all the latest and breaking news from Eyewire+. Compare headlines and media bias behind news outlets on stories breaking today.

In total, 128 have been published by Eyewire+ which Ground News has aggregated in the past 3 months.

Eyewire+’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Eyewire+’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Eyewire+

Where is Eyewire+ located?Eyewire+'s Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Eyewire+ News

Uniqlo owner warns significant tariff impact, plans price hikes

Trade War · Japan

Uniqlo owner warns significant tariff impact, plans price hikes

69% Center coverage: 13 sources

Nanoscope Begins Rolling Submission of Biologics License Application for RP Gene Therapy

United States · United States

Nanoscope Begins Rolling Submission of Biologics License Application for RP Gene Therapy

100% Center coverage: 2 sources

Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene therapy to treat severe vision loss in retinitis pigmentosa, to the FDA, according to a press release.See the Story

AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, ...

United States · United States

AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, ...

Coverage: 2 sources

AAVB-039 delivers the full-length ABCA4 -protein, addressing the root cause of the disease and enabling treatment of all patients, independent of mutationCELESTE is informed by the STELLA prospective natural history study, which is currently enrolling patients in the United States…See the Story

FDA fast-tracks Sanofi's gene therapy for eye disease GA

100% Center coverage: 1 sources

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy, a major cause of blindnessAMD · United States See the Story

Nicox and Kowa Sign Agreement for Exclusive Rights to Glaucoma Treatment NCX 470 in US and All Unlicensed Territories

100% Center coverage: 1 sources

Kowa has gained exclusive rights to develop and commercialize NCX 470, Nicox’s nitric oxide (NO)-donating bimatoprost eye drop for the lowering of IOP in patients with glaucoma or ocular hypertension in the US and all other territories of the world excluding Japan, China, Korea and Southeast Asia. Kowa already has a license to NCX 470 for Japan, where it is preparing to enter a phase 3 clinical trial. NCX 470 is also licensed to Ocumension The…FDA · United States See the Story

Stuart Therapeutics Publishes New Study Demonstrating Potential of Collagen Mimetic Peptides in Treating Ophthalmic Disease

Stuart Therapeutics announced the publication of a preclinical study in Pharmaceuticals highlighting the potential of collagen mimetic peptides (CMPs) in restoring ocular tissue integrity and combating diseases such as myopia. The study provides evidence that CMPs, designed to bind to and repair damaged collagen, can help restore the stiffness of ocular tissues that have been compromised by stress, such as elevated IOP. Specifically, the researc…Pharma · Nashville Read Article

EyeDura's Eye Drop Technology Recognized by Eye Care Industry

The Topical Sustain Release drop technology was designed to address suboptimal patient compliance and high treatment cost.Startups See the Story

Wayne Caulder Joins Bausch + Lomb as Vice President and General Manager, Surgical, US

Wayne Caulder has joined Bausch + Lomb as vice president and general manager, Surgical, US and Canada. Mr. Caulder brings more than 30 years of experience in the eye health industry across multiple therapeutic categories, including cataract and refractive surgery, retina and retina surgery, age-related macular degeneration disease management, dry eye, cornea surgery and glaucoma. He previously served as President of North America and Co-Founder …United States · United States Read Article

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients

Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.Canada · Canada See the Story

Johnson & Johnson Appoints Kelly Heaps, Vice President of US Sales, Vision Care

Johnson & Johnson announced the appointment of Kelly Heaps as Vice President of US Sales, Vision Care. As the leader of the US Sales Organization, Ms. Heaps will work to accelerate sales and foster market share growth while collaborating with customers to strengthen patient outcomes. "Kelly's passion for healthcare and extensive experience in leading professional-focused teams will be invaluable in driving our mission forward. We are confident t…United States · United States Read Article

FDA Approves Label Change for Alzheimer's Amyloid Drug

Coverage: 2 sources

Brain edema risk expected to be less with new donanemab dosing scheduleAlzheimer's Disease · United States See the Story

Breaking News Topics Related to Eyewire+